Molecular diagnostics sales surge in Hologic's Q3

By staff writers

July 30, 2020 -- A strong surge in sales of its molecular diagnostics products helped Hologic offset declines in other areas of the company's business in its third fiscal quarter.

For the quarter (end-June 27), Hologic reported revenue of $822.9 million, compared with $852.4 million in the same quarter of 2019. The 3.5% decline was due to the loss of sales from Hologic's Cynosure division, which it sold in January.

On the positive side, Hologic reported that its Diagnostics division had third-quarter sales of $460.3 million, up 169% compared with 2019. The higher numbers reflect strong sales of the company's two SARS-CoV-2 assays that run on its Panther and Panther Fusion systems.

On the other hand, the company's Breast Health segment posted sales of $224 million, a decline of 31% compared with the same quarter in 2019.

The company's net income for the quarter was $137.9 million, an increase of 47% from the third quarter of 2019, when it posted net income of $93.9 million. Hologic attributed the increase in net income and organic revenue to strong sales of its two COVID-19 diagnostics.

Labcorp reports revenue dip in Q2
The COVID-19 pandemic resulted in a 3.9% drop in revenue for Labcorp in its second quarter.
Roche's strong COVID-19 test sales help offset losses in routine screens
Strong performance in Roche's molecular diagnostics business -- COVID-19 tests in particular -- for the first half of the year helped offset losses for...
Thermo Fisher posts 10% growth in Q2
Thermo Fisher Scientific reported financial results for the second quarter, noting 10% revenue growth.
FDA gives Hologic EUA for SARS-CoV-2 test
The U.S. Food and Drug Administration (FDA) gave Hologic emergency use authorization (EUA) for its Aptima SARS-CoV-2 molecular test for detection of the...
Hologic molecular test helps Quest avoid coronavirus backlog
Thanks in part to the use of a molecular test from Hologic, Quest Diagnostics has reported another increase in the volume of novel coronavirus diagnostics...

Copyright © 2020

Last Updated ls 7/30/2020 1:57:42 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current